generations of glp 1 agonists Revolutionizing obesity treatment: The emerging role GLP-1 receptor and next-generation pharmacotherapies Structures of formulations of GLP-1

Following its secretion from gut endocrine cells, GLP-2 promotes the absorption of nutrients through distinct mechanisms of action [66]

While some patients experience diarrhea, others develop constipation, and many notice changes in bowel frequency or consistency

In preclinical models, GIP receptor agonism attenuates emesis while increasing the amount of body weight reduction in comparison to GLP- 1 agonism alone [148]

Adverse effects are similar in patients using the medication for diabetes to those using the medication for weight loss [67]

[1] [2] The potential interaction between allulose consumption and GLP-1 activity has emerged as an area of scientific interest

Diabetologia 61 , 21082117 (2018)